BLUEJET
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Blue Jet Healthcare Dec-Quarter Profit 989.8 Mln Rupees
Jan 29 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
DEC-QUARTER PROFIT 989.8 MILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 3.18 BILLION RUPEES
BOARD APPROVES INVESTMENTS OF UP TO 400 MILLION RUPEES FOR RESEARCH AND DEVELOPMENT FACILITY
Source text: ID:nBSE57qK0s
Further company coverage: BLUJ.NS
(([email protected];;))
Jan 29 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
DEC-QUARTER PROFIT 989.8 MILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 3.18 BILLION RUPEES
BOARD APPROVES INVESTMENTS OF UP TO 400 MILLION RUPEES FOR RESEARCH AND DEVELOPMENT FACILITY
Source text: ID:nBSE57qK0s
Further company coverage: BLUJ.NS
(([email protected];;))
Elpro International Acquires Shares Of Blue Jet Healthcare For 75.4 Mln Rupees
Dec 17 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
ACQUIRED SHARES OF BLUE JET HEALTHCARE FOR 75.4 MILLION RUPEES
Source text: ID:nBSE2qlT9j
Further company coverage: BLUJ.NS
(([email protected];;))
Dec 17 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
ACQUIRED SHARES OF BLUE JET HEALTHCARE FOR 75.4 MILLION RUPEES
Source text: ID:nBSE2qlT9j
Further company coverage: BLUJ.NS
(([email protected];;))
India's Blue Jet Healthcare up after starting manufacturing at plant
** Shares of India's Blue Jet Healthcare BLUJ.NS up 3.2% to 417 rupees after rising as much as 5.2% earlier in the session
** Drugmaker said it has started manufacturing at its facility in Ambernath, Maharashtra
** Co proposes to commercialize full scale production within next six months, existing capacity utilization is 70% of total
** YTD stock had risen 13.3%
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
** Shares of India's Blue Jet Healthcare BLUJ.NS up 3.2% to 417 rupees after rising as much as 5.2% earlier in the session
** Drugmaker said it has started manufacturing at its facility in Ambernath, Maharashtra
** Co proposes to commercialize full scale production within next six months, existing capacity utilization is 70% of total
** YTD stock had risen 13.3%
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
Blue Jet Healthcare Receives Approval From Maharashtra State Electricity Distribution Co
Jan 4 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
RECEIVED APPROVAL FROM MAHARASHTRA STATE ELECTRICITY DISTRIBUTION CO
RECEIVED PERMISSION TO COMMISSION FOR SYNCHRONIZATION OF 5.615 MW PLANT CAPACITY IN 15 MW SOLAR PARK
Source text for Eikon: ID:nBSEbDK7XT
Further company coverage: BLUJ.NS
(([email protected];))
Jan 4 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
RECEIVED APPROVAL FROM MAHARASHTRA STATE ELECTRICITY DISTRIBUTION CO
RECEIVED PERMISSION TO COMMISSION FOR SYNCHRONIZATION OF 5.615 MW PLANT CAPACITY IN 15 MW SOLAR PARK
Source text for Eikon: ID:nBSEbDK7XT
Further company coverage: BLUJ.NS
(([email protected];))
Blue Jet Healthcare Received Order For Closure Of One Of Co's Units
Nov 9 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
BLUE JET HEALTHCARE LTD - RECEIVED ORDER BY MAHARASHTRA POLLUTION CONTROL BOARD FOR CLOSURE OF ONE OF CO'S UNITS
BLUE JET HEALTHCARE LTD - CANNOT RESUME MANUFACTURING ACTIVITY TILL FURTHER ORDERS FROM MPCB
Source text for Eikon: ID:nNSE2hm8ZR
Further company coverage: BLUJ.NS
(([email protected];))
Nov 9 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
BLUE JET HEALTHCARE LTD - RECEIVED ORDER BY MAHARASHTRA POLLUTION CONTROL BOARD FOR CLOSURE OF ONE OF CO'S UNITS
BLUE JET HEALTHCARE LTD - CANNOT RESUME MANUFACTURING ACTIVITY TILL FURTHER ORDERS FROM MPCB
Source text for Eikon: ID:nNSE2hm8ZR
Further company coverage: BLUJ.NS
(([email protected];))
Blue Jet Healthcare Says Fire Incident Occurred On November 3 At Mahad Plant
Nov 3 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
FIRE INCIDENT OCCURRED ON NOVEMBER 3 AT COMPANY'S MAHAD PLANT
CO IS IN PROCESS OF EVALUATING EXTENT OF DAMAGE CAUSED AND HAVE STARTED NECESSARY PROCEDURES
FIRE WAS EXTINGUISHED WITHIN TIME WITH HELP OF FIRE DEPARTMENT
COMPANY HAS ADEQUATE INSURANCE COVERAGE FOR ASSETS IN SAID PLANT.
Source text for Eikon: ID:nBSE2mMw1l
Further company coverage: BLUJ.NS
(([email protected];))
Nov 3 (Reuters) - Blue Jet Healthcare Ltd BLUJ.NS:
FIRE INCIDENT OCCURRED ON NOVEMBER 3 AT COMPANY'S MAHAD PLANT
CO IS IN PROCESS OF EVALUATING EXTENT OF DAMAGE CAUSED AND HAVE STARTED NECESSARY PROCEDURES
FIRE WAS EXTINGUISHED WITHIN TIME WITH HELP OF FIRE DEPARTMENT
COMPANY HAS ADEQUATE INSURANCE COVERAGE FOR ASSETS IN SAID PLANT.
Source text for Eikon: ID:nBSE2mMw1l
Further company coverage: BLUJ.NS
(([email protected];))
Indian cookware maker Cello World's IPO garners strong response
By Rama Venkat
BENGALURU, Nov 1 (Reuters) - Indian kitchenware products maker Cello World's initial public offering (IPO) was oversubscribed by nearly 40 times, higher than similar IPOs recently, inviting bids worth 556.19 billion rupees ($6.7 billion), exchange data showed on Wednesday.
Investors bid for more than 858.3 million shares, compared with the 22 million shares on offer, with institutional investors showing the most interest, the data showed.
"Despite markets being on weaker note, Cello World offer received an overwhelming response, although retail investors remained cautious as IPO has only an offer for share sale from existing stakeholders," said Prashant Tapse, senior vice president (research) at Mehta Equities.
Cello World's shareholders -- including its promoters, an Indian market term for large shareholders who can influence company policy -- are selling stock worth 19 billion rupees in the IPO, while the company itself if not offering any shares.
Other IPOs where the company did not sell shares have seen tepid interest. For example, the IPOs of Blue Jet Healthcare BLUJ.NS, Mankind Pharma MNKI.NS and Concord Biotech CONB.NS were oversubscribed 7-27 times.
Cello World has set a price band of 617-648 rupees per share for the IPO. At the top end, it will be valued at 137.53 billion rupees, three times rival Borosil's BORS.BO market value and nearly seven times that of Stovekraft STVE.NS and Butterfly Gandhimathi Appliances BUTT.NS.
"On valuation, it seems the issue is reasonably priced, reflecting an expected revenue and profit growth," said Tapse.
The company's consolidated net profit jumped 25.2% year-over-year to 774.4 million rupees in the quarter ended June 30, while revenue rose 9%.
In that same period, Borosil's profit shrunk 62.5% due to higher raw material costs, while revenue climbed 16%.
Cello World is expected to list on the stock exchanges on Monday.
Kotak Mahindra Capital and ICICI Securities were among the lead IPO's managers.
($1 = 83.2840 Indian rupees)
(Reporting by Rama Venkat in Bengaluru; Editing by Savio D'Souza)
(([email protected]; https://twitter.com/ramavenkat0607; +91 8095218099;))
By Rama Venkat
BENGALURU, Nov 1 (Reuters) - Indian kitchenware products maker Cello World's initial public offering (IPO) was oversubscribed by nearly 40 times, higher than similar IPOs recently, inviting bids worth 556.19 billion rupees ($6.7 billion), exchange data showed on Wednesday.
Investors bid for more than 858.3 million shares, compared with the 22 million shares on offer, with institutional investors showing the most interest, the data showed.
"Despite markets being on weaker note, Cello World offer received an overwhelming response, although retail investors remained cautious as IPO has only an offer for share sale from existing stakeholders," said Prashant Tapse, senior vice president (research) at Mehta Equities.
Cello World's shareholders -- including its promoters, an Indian market term for large shareholders who can influence company policy -- are selling stock worth 19 billion rupees in the IPO, while the company itself if not offering any shares.
Other IPOs where the company did not sell shares have seen tepid interest. For example, the IPOs of Blue Jet Healthcare BLUJ.NS, Mankind Pharma MNKI.NS and Concord Biotech CONB.NS were oversubscribed 7-27 times.
Cello World has set a price band of 617-648 rupees per share for the IPO. At the top end, it will be valued at 137.53 billion rupees, three times rival Borosil's BORS.BO market value and nearly seven times that of Stovekraft STVE.NS and Butterfly Gandhimathi Appliances BUTT.NS.
"On valuation, it seems the issue is reasonably priced, reflecting an expected revenue and profit growth," said Tapse.
The company's consolidated net profit jumped 25.2% year-over-year to 774.4 million rupees in the quarter ended June 30, while revenue rose 9%.
In that same period, Borosil's profit shrunk 62.5% due to higher raw material costs, while revenue climbed 16%.
Cello World is expected to list on the stock exchanges on Monday.
Kotak Mahindra Capital and ICICI Securities were among the lead IPO's managers.
($1 = 83.2840 Indian rupees)
(Reporting by Rama Venkat in Bengaluru; Editing by Savio D'Souza)
(([email protected]; https://twitter.com/ramavenkat0607; +91 8095218099;))
Upcoming Events:
e-Voting
Events:
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Blue Jet Healthcare do?
Blue Jet Healthcare (Formerly known as Bluejet Healthcare Private Limited) is a Public Limited Company (converted from private limited to public limited company on May 18, 2022) incorporated in India having its registered office at Navi Mumbai, Maharashtra. The company is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare products.
Who are the competitors of Blue Jet Healthcare?
Blue Jet Healthcare major competitors are Divi's Lab, Laurus Labs, Caplin Point Lab, Natco Pharma, Sai Life Sciences, Neuland Laboratories, Sanofi India. Market Cap of Blue Jet Healthcare is ₹15,654 Crs. While the median market cap of its peers are ₹15,913 Crs.
Is Blue Jet Healthcare financially stable compared to its competitors?
Blue Jet Healthcare seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Blue Jet Healthcare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Blue Jet Healthcare latest dividend payout ratio is 10.59% and 3yr average dividend payout ratio is 10.59%
How has Blue Jet Healthcare allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress
How strong is Blue Jet Healthcare balance sheet?
Balance sheet of Blue Jet Healthcare is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Blue Jet Healthcare improving?
Yes, profit is increasing. The profit of Blue Jet Healthcare is ₹305 Crs for TTM, ₹164 Crs for Mar 2024 and ₹160 Crs for Mar 2023.
Is the debt of Blue Jet Healthcare increasing or decreasing?
Yes, The net debt of Blue Jet Healthcare is increasing. Latest net debt of Blue Jet Healthcare is -₹119.79 Crs as of Mar-25. This is greater than Mar-24 when it was -₹169.38 Crs.
Is Blue Jet Healthcare stock expensive?
Yes, Blue Jet Healthcare is expensive. Latest PE of Blue Jet Healthcare is 51.29, while 3 year average PE is 48.52. Also latest EV/EBITDA of Blue Jet Healthcare is 41.13 while 3yr average is 37.56.
Has the share price of Blue Jet Healthcare grown faster than its competition?
Blue Jet Healthcare has given better returns compared to its competitors. Blue Jet Healthcare has grown at ~141.62% over the last 1yrs while peers have grown at a median rate of 48.0%
Is the promoter bullish about Blue Jet Healthcare?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Blue Jet Healthcare is 86.0% and last quarter promoter holding is 86.0%.
Are mutual funds buying/selling Blue Jet Healthcare?
The mutual fund holding of Blue Jet Healthcare is decreasing. The current mutual fund holding in Blue Jet Healthcare is 0.62% while previous quarter holding is 1.19%.